Last reviewed · How we verify
Experimental group: Budicort by Inhalation
Experimental group: Budicort by Inhalation is a Corticosteroid Small molecule drug developed by Bnai Zion Medical Center. It is currently in Phase 2 development for Chronic obstructive pulmonary disease (COPD), Asthma.
Budicort by Inhalation is a corticosteroid that reduces inflammation in the lungs.
Budicort by Inhalation is a corticosteroid that reduces inflammation in the lungs. Used for Chronic obstructive pulmonary disease (COPD), Asthma.
At a glance
| Generic name | Experimental group: Budicort by Inhalation |
|---|---|
| Sponsor | Bnai Zion Medical Center |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 2 |
Mechanism of action
Budicort by Inhalation works by inhibiting the production of inflammatory mediators in the lungs, thereby reducing inflammation and improving symptoms in patients with respiratory conditions.
Approved indications
- Chronic obstructive pulmonary disease (COPD)
- Asthma
Common side effects
- Oral thrush
- Headache
- Cough
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Experimental group: Budicort by Inhalation CI brief — competitive landscape report
- Experimental group: Budicort by Inhalation updates RSS · CI watch RSS
- Bnai Zion Medical Center portfolio CI
Frequently asked questions about Experimental group: Budicort by Inhalation
What is Experimental group: Budicort by Inhalation?
How does Experimental group: Budicort by Inhalation work?
What is Experimental group: Budicort by Inhalation used for?
Who makes Experimental group: Budicort by Inhalation?
What drug class is Experimental group: Budicort by Inhalation in?
What development phase is Experimental group: Budicort by Inhalation in?
What are the side effects of Experimental group: Budicort by Inhalation?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: Bnai Zion Medical Center — full pipeline
- Therapeutic area: All drugs in Respiratory
- Indication: Drugs for Chronic obstructive pulmonary disease (COPD)
- Indication: Drugs for Asthma
- Compare: Experimental group: Budicort by Inhalation vs similar drugs
- Pricing: Experimental group: Budicort by Inhalation cost, discount & access